Edges in Network
Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | FOXC1 |
Upstream (Parents) |
---|
(<<) SPDEF → FOXC1 |
Downstream (Children) |
---|
FOXC1 → CMTM7 (>>) |
FOXC1 → SYT17 (>>) |
FOXC1 → CIB1 (>>) |
FOXC1 → KRT6B (>>) |
FOXC1 → CXorf61 (>>) |
FOXC1 → SLC6A14 (>>) |
FOXC1 → IRX1 (>>) |
FOXC1 → TMEM205 (>>) |
FOXC1 → HPX (>>) |
FOXC1 → FAM171A1 (>>) |
FOXC1 → CHI3L2 (>>) |
FOXC1 → ETNK2 (>>) |
FOXC1 → KCNK5 (>>) |
FOXC1 → MAP2 (>>) |
FOXC1 → TFCP2L1 (>>) |
FOXC1 → TSPAN15 (>>) |
FOXC1 → VANGL2 (>>) |
FOXC1 → BCL11A (>>) |
FOXC1 → KCTD14 (>>) |
FOXC1 → FZD7 (>>) |
FOXC1 → LOC440995 (>>) |
FOXC1 → FOXD1 (>>) |
FOXC1 → RGMA (>>) |
FOXC1 → TMEM200C (>>) |
FOXC1 → STOX2 (>>) |
FOXC1 → PCDH8 (>>) |
FOXC1 → LOC727973///FLJ37644 (>>) |
FOXC1 → TRIM2 (>>) |
FOXC1 → DUSP10 (>>) |
FOXC1 → TCF7L2 (>>) |
FOXC1 → DSC2 (>>) |
FOXC1 → CA13 (>>) |
FOXC1 → PADI3 (>>) |
FOXC1 → ZNF462 (>>) |
FOXC1 → IL17RD (>>) |
FOXC1 → EFNA5 (>>) |
FOXC1 → UGT2B15 (>>) |
FOXC1 → HOXB2 (>>) |
FOXC1 → MARCH3 (>>) |
FOXC1 → TET1 (>>) |